Shire - Biochem Inc.

Address(es) and Telephone No(s).

Address: 275 Armand-Frappier Blvd.
Laval Quebec H7V 4A7, Canada
Phone: 1-450-978-7800
Fax: 1-450-978-7755

Company Overview

Shire-Biochem Pharma (formerly BioChem Pharma, now a subsidiary of the UK's Shire Pharmaceuticals) runs with the big boys. Through an alliance with UK pharmaceutical giant Glaxo Wellcome (now GlaxoSmithKline), the Laval operation developed 3TC (marketed outside of Canada as Epivir), the world's bestselling HIV treatment, which is used with Glaxo's Retrovir for the treatment of AIDS; and Zeffix, which is sold in over 30 countries for the treatment of chronic hepatitis B. Shire-BioChem also makes vaccines for the flu (FluviralMC), meningitis, and pneumonia, and is developing treatments for bladder cancer (Pacis).

Local Activities

In Laval, Shire-Biochem is now working on (among other things):

  • TroxatylMC (troxacitabine), an anti-cancer agent for the treatment of several kinds of leukaemia and various solid tumours.
  • BCH-3963/LEF, a new analgesic developed in collaboration with AstraZeneca.
  • BCH-10618 and BCH-13520, two potential anti-HIV products.
CEO and other Corporate Officers

CEO: Joseph Rus

Vital Statistics (sales, # of employees...)

2000 Sales (mil.): 216.80

Employees: 500

Revenue per employee: $433,600.00

Additional Information, Reports, and Disclosures
Links

On 3TC

If you have information that you feel should be made public regarding the activities of this corporation, send it to [email protected] Include as much factual content as possible to back up your claims. Thank you.

Hosted by www.Geocities.ws

1